Aspen Aerogels (NYSE:ASPN) Hits New 1-Year Low - Time to Sell?

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) reached a new 52-week low on Thursday . The company traded as low as $8.80 and last traded at $9.04, with a volume of 828294 shares trading hands. The stock had previously closed at $11.75.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Craig Hallum dropped their target price on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a report on Friday. Seaport Res Ptn lowered shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th. StockNews.com upgraded shares of Aspen Aerogels to a "sell" rating in a research note on Saturday, February 8th. Roth Mkm reduced their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a research report on Friday. Finally, Barclays cut their target price on Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Tuesday, November 12th. One analyst has rated the stock with a sell rating, one has given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $24.67.

Aspen Aerogels Stock Down 3.7 %

The company's 50 day moving average price is $12.17 and its two-hundred day moving average price is $18.45. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The stock has a market cap of $711.05 million, a P/E ratio of 867.47 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. Equities analysts forecast that Aspen Aerogels, Inc. will post 0.12 earnings per share for the current year.

Hedge Funds Weigh In On Aspen Aerogels

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ASPN. Lord Abbett & CO. LLC bought a new position in shares of Aspen Aerogels during the 3rd quarter valued at approximately $10,126,000. Oppenheimer & Co. Inc. grew its holdings in shares of Aspen Aerogels by 167.2% in the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company's stock worth $2,839,000 after purchasing an additional 64,154 shares during the last quarter. Sanders Morris Harris LLC boosted its position in Aspen Aerogels by 337.5% in the 4th quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company's stock valued at $436,000 after buying an additional 27,000 shares during the period. Penserra Capital Management LLC bought a new stake in shares of Aspen Aerogels during the third quarter valued at approximately $1,342,000. Finally, Geode Capital Management LLC boosted its holdings in shares of Aspen Aerogels by 5.7% in the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company's stock valued at $38,385,000 after purchasing an additional 75,024 shares during the period. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.